Pre-operative T-stage discrimination in gallbladder cancer using machine learning and DeepSeek-R1
Joongwon Chae1, Zhenyu Wang1, Duanpo Wu2
1Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen, Guangdong, China.
Routine blood biomarkers failed to distinguish early gallbladder cancer (GBC) stages. A large language model analyzing radiology reports achieved high accuracy, showing potential for guiding GBC surgical strategy.
Area of Science:
- Oncology
- Medical Informatics
- Machine Learning
Background:
- Gallbladder cancer (GBC) often presents with non-specific symptoms, delaying diagnosis.
- Early detection of GBC T-stages is crucial for effective treatment planning and patient outcomes.
Purpose of the Study:
- To assess if routine blood biomarkers can differentiate early GBC T-stages using machine learning.
- To compare the T-stage discrimination performance of a large language model (DeepSeek-R1) using radiology reports alone versus reports plus biomarker data.
Main Methods:
- Retrospective analysis of 232 GBC patients, classifying T1 and T2 stages.
- Training machine learning models (Random Forest, SVC, XGBoost, LightGBM) with seven blood biomarkers (NLR, MLR, PLR, CEA, CA19-9, CA125, AFP).
- Evaluating DeepSeek-R1's performance in classifying T1 vs. T2 GBC using radiology reports with and without biomarker data.
Main Results:
- Biomarker-based machine learning models showed poor T-stage discrimination, with performance near random chance.
- Synthetic Minority Over-sampling Technique (SMOTE) did not improve performance on the independent test set.
- DeepSeek-R1 achieved 89.6% accuracy using only radiology report text, identifying features like 'gallbladder wall thickening' for T2 classification; biomarker data did not enhance this accuracy.
Conclusions:
- Routine blood biomarkers are ineffective for early GBC T-stage discrimination.
- A radiology text-driven large language model demonstrates high accuracy and interpretability, offering potential for clinical decision support in GBC.
- Further multi-center studies are needed to validate these findings in larger GBC cohorts.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
